<SEC-DOCUMENT>0001140361-19-013027.txt : 20190716
<SEC-HEADER>0001140361-19-013027.hdr.sgml : 20190716
<ACCEPTANCE-DATETIME>20190716172057
ACCESSION NUMBER:		0001140361-19-013027
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190716
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190716
DATE AS OF CHANGE:		20190716

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NU SKIN ENTERPRISES INC
		CENTRAL INDEX KEY:			0001021561
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				870565309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12421
		FILM NUMBER:		19957749

	BUSINESS ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: GREGORY BELLISTON
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601
		BUSINESS PHONE:		801-345-1000

	MAIL ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: GREGORY BELLISTON
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ASIA PACIFIC INC
		DATE OF NAME CHANGE:	19960919
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 6.1.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  <div></div>
  <div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 18pt; font-weight: bold;">FORM 8-K</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">CURRENT REPORT</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zc7966be3a1cf480596233aa280ef0f8a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 23.37%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 53.12%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-weight: bold;">July 16, 2019</div>
          </td>
          <td style="width: 23.51%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 23.37%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 53.12%; vertical-align: top;">
            <div style="text-align: center; color: #000000;">Date of Report (Date of earliest event reported)</div>
          </td>
          <td style="width: 23.51%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z96e01d03dcc64b62b7ddfd35931f4a10" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 23.37%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="border-bottom: 2px solid #000000; vertical-align: bottom; white-space: nowrap; width: 53.12%; font-size: 24pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">NU SKIN ENTERPRISES, INC.</div>
          </td>
          <td style="width: 23.51%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 23.37%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 53.12%; vertical-align: top;">
            <div style="text-align: center; color: #000000;">(Exact name of registrant as specified in its charter)</div>
          </td>
          <td style="width: 23.51%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z62b8720e24be4366b9e97936d3216c09" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 23.37%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-weight: bold;">Delaware</div>
          </td>
          <td style="width: 12.92%; vertical-align: bottom;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 26.56%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-weight: bold;">001-12421</div>
          </td>
          <td style="width: 13.64%; vertical-align: bottom;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 23.51%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-weight: bold;">87-0565309</div>
          </td>
        </tr>
        <tr>
          <td style="width: 23.37%; vertical-align: top;">
            <div style="text-align: center; color: #000000;">(State or other jurisdiction of incorporation)</div>
          </td>
          <td style="width: 12.92%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 26.56%; vertical-align: top;">
            <div style="text-align: center; color: #000000;">(Commission File Number)</div>
          </td>
          <td style="width: 13.64%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 23.51%; vertical-align: top;">
            <div style="text-align: center; color: #000000;">(IRS Employer Identification Number)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zd1e45c416e014309bbd7195c6bd99872" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 23.37%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 53.12%; vertical-align: middle; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-weight: bold;">75 West Center Street</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Provo, Utah 84601</div>
          </td>
          <td style="width: 23.51%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 23.37%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 53.12%; vertical-align: top;">
            <div style="text-align: center; color: #000000;">(Address of principal executive offices and zip code)</div>
          </td>
          <td style="width: 23.51%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z419a89fbde7d418fa6731af80fd95347" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 23.37%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 53.12%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-weight: bold;">(801) 345-1000</div>
          </td>
          <td style="width: 23.51%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 23.37%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 53.12%; vertical-align: top;">
            <div style="text-align: center; color: #000000;">(Registrant's telephone number, including area code)</div>
          </td>
          <td style="width: 23.51%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z0e126746dc114990998e86ef4df9aba4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 23.37%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td style="width: 53.12%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000; font-weight: bold;">N/A</div>
          </td>
          <td style="width: 23.51%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 23.37%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 53.12%; vertical-align: top;">
            <div style="text-align: center; color: #000000;">(Former name or former address, if changed since last report)</div>
          </td>
          <td style="width: 23.51%; vertical-align: top;">
            <div style="color: #000000;">&#160;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: #000000;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
      following provisions:</div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z2f32d400dd5f42ac9e3751430f1ccd69" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 27pt; vertical-align: top; align: right; color: #000000;">&#9744;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" id="zbbd2881e00104565b99985b9a79bea3a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 27pt; vertical-align: top; align: right; color: #000000;">&#9744;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z822768ec13bb44a08585033250f330fe" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 27pt; vertical-align: top; align: right; color: #000000;">&#9744;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" id="zfae6df92ec2a41d89b0ae9a2c108aa4e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 27pt; vertical-align: top; align: right; color: #000000;">&#9744;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="color: #000000;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div style="color: #000000;">Securities registered pursuant to Section 12(b) of the Act:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z0c3173df2afa4dccb04c1fc8433fe3c3" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27.04%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000;">Title of each class</div>
          </td>
          <td style="width: 31.13%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000;">Trading Symbol(s)</div>
          </td>
          <td style="width: 41.83%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000;">Name of each exchange on which registered</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27.04%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000;">Class A Common Stock</div>
          </td>
          <td style="width: 31.13%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000;">NUS</div>
          </td>
          <td style="width: 41.83%; vertical-align: top; border-left: #000000 2px solid; border-right: #000000 2px solid; border-top: #000000 2px solid; border-bottom: #000000 2px solid;">
            <div style="text-align: center; color: #000000;">New York Stock Exchange</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of
      the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>
    <div> <br>
    </div>
    <div style="text-align: right;">Emerging growth company &#9744;</div>
    <div> <br>
    </div>
    <div>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>
    <div><font style="color: #000000;"> <br>
      </font></div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><font style="font-weight: bold;">Item 2.02</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Results of Operations and
        Financial Condition.</font></div>
    <div><br>
    </div>
    <div>On July 16, 2019, Nu Skin Enterprises, Inc. issued a press release announcing its preliminary financial results for the quarter ended June 30, 2019, and certain other
      information. A copy of the press release is attached as Exhibit 99.1 to this report.</div>
    <div><br>
    </div>
    <div>The information furnished pursuant to this Item 2.02 and the exhibit hereto shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934,
      as amended (the &#8220;Exchange Act&#8221;), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.</div>
    <div><br>
    </div>
    <div><font style="font-weight: bold;">Item 9.01</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;">Financial Statements and
        Exhibits.</font></div>
    <div><br>
    </div>
    <div>(d) Exhibit.</div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" id="zdc60c4a882114c879960f9cb0440d860" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;"><a href="ex99_1.htm">99.1</a></td>
              <td style="width: auto; vertical-align: top;">
                <div>Nu Skin Enterprises&#8217; press release dated July 16, 2019, regarding financial results for the quarter ended June 30, 2019.</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
      </div>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">SIGNATURE</div>
    <div><br>
    </div>
    <div style="color: #000000;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z9c147e49b45c42229741b6ab88c8c867" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45.3%; vertical-align: top;">&#160;</td>
          <td style="width: 54.7%; vertical-align: top;" colspan="2">
            <div style="color: #000000; font-weight: bold;">NU SKIN ENTERPRISES, INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 45.3%; vertical-align: top;">&#160;</td>
          <td style="width: 33.83%; vertical-align: top;">
            <div style="color: #000000;">(Registrant)</div>
          </td>
          <td style="width: 20.86%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45.3%; vertical-align: top;">&#160;</td>
          <td style="width: 33.83%; vertical-align: top;">&#160;</td>
          <td style="width: 20.86%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45.3%; vertical-align: top;">&#160;</td>
          <td style="width: 33.83%; vertical-align: top; border-bottom: 2px solid black;">
            <div style="color: #000000;">/s/ Mark H. Lawrence</div>
          </td>
          <td style="width: 20.86%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45.3%; vertical-align: top;">&#160;</td>
          <td style="width: 33.83%; vertical-align: top;">
            <div style="color: #000000;">Mark H. Lawrence</div>
          </td>
          <td style="width: 20.86%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 45.3%; vertical-align: top;">&#160;</td>
          <td style="width: 33.83%; vertical-align: top;">
            <div style="color: #000000;">Chief Financial Officer</div>
          </td>
          <td style="width: 20.86%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="color: #000000;">Date:&#160; July 16, 2019</div>
    <div style="color: #000000;"> <br>
    </div>
  </div>
  <div><br>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99_1.htm
<DESCRIPTION>PRESS RELEASE DATED JULY 16, 2019
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 6.1.0.0
         Copyright 1995 - 2019 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div><br>
  </div>
  <div><br>
  </div>
  <div><img src="image00001.jpg"></div>
  <div><br>
  </div>
  <div>
    <div style="color: #000000; font-weight: bold;">FOR IMMEDIATE RELEASE</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">NU SKIN ENTERPRISES PROVIDES ESTIMATED SECOND-QUARTER RESULTS<br>
      AND UPDATES 2019 OUTLOOK</div>
    <div><br>
    </div>
    <div>PROVO, Utah &#8212; July 16, 2019 &#8212; Nu Skin Enterprises, Inc. (NYSE: NUS) today announced estimated second-quarter results and updated its outlook for full-year 2019. The company anticipates reporting second-quarter revenue between $622 and $623 million
      and earnings per share of $0.82 to $0.84. The company&#8217;s revised revenue outlook for 2019 is $2.48 to $2.52 billion with a negative foreign currency impact of approximately 4 percent, and earnings per share of $3.20 to $3.35.</div>
    <div><br>
    </div>
    <div>&#8220;We are adjusting our guidance for the year primarily due to a reduced revenue outlook in Mainland China following the government&#8217;s 100-day campaign to review and inspect the health products and direct selling industries,&#8221; said Ritch Wood, chief
      executive officer. &#8220;Continued restrictions on sales meetings, as well as media scrutiny, have negatively impacted consumer sentiment and contributed to this adjustment. While we anticipated we could begin holding meetings in the second quarter,
      meeting approvals for the industry have been significantly more restrictive than expected and remain limited. Additionally, the U.S. dollar has continued to strengthen, and we have adjusted our 2019 guidance to include a larger-than-anticipated
      foreign currency impact. We will provide more detail regarding results for the second quarter in our earnings release scheduled for Aug. 6.&#8221;</div>
    <div><br>
    </div>
    <div>The company&#8217;s second-quarter earnings release and a management-led conference call will take place after the market close on Tuesday, Aug. 6. The call will begin at 5 p.m. ET and will be webcast on the investor relations section of the company's
      website at ir.nuskin.com. The financial information to be presented will also be available on the investor relations section of the company&#8217;s website. A replay of the webcast will be available at the same location through&#160;Tuesday, Aug. 20.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageFooter"></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="font-weight: bold;">About Nu Skin Enterprises, Inc.</div>
    <div>Founded 35 years ago, Nu Skin Enterprises, Inc. (NSE) empowers innovative companies to change the world with sustainable solutions, opportunities, technologies, and life-improving values. The company currently focuses its efforts around innovative
      consumer products, product manufacturing and controlled environment agriculture technology. The NSE family of companies includes Nu Skin, which develops and distributes a comprehensive line of premium-quality beauty and wellness solutions through a
      global network of sales leaders in Asia, the Americas, Europe, Africa and the Pacific; and a collection of sustainable manufacturing and technology innovation companies. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol
      "NUS." More information is available at nuskinenterprises.com.</div>
    <div><br>
    </div>
    <div style="font-style: italic;"><font style="font-weight: bold;">Important Information Regarding Forward-Looking Statements:</font> This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
      as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company&#8217;s current expectations and beliefs. All statements other than statements of historical fact are &#8220;forward-looking statements&#8221; for purposes of
      federal and state securities laws and include, but are not limited to, estimates and projections of the company&#8217;s revenue, earnings per share and foreign-currency impacts for both the second quarter of 2019 and the full-year 2019; statements related
      to the timing of the release of the company&#8217;s full financial results for the second quarter of 2019; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as
      &#8220;outlook,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;guidance,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; the negative of these words and other similar words.</div>
    <div><br>
    </div>
    <div style="font-style: italic;">The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein.
      These risks and uncertainties include, but are not limited to, the following:</div>
    <div><br>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z80297f8043d748a9b55584d47a9bd2fa">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">estimates and guidance concerning anticipated revenue, earnings per share and foreign-currency impacts are preliminary, and actual results may differ from the estimates and guidance provided based on a
                  number of factors, including different-from-anticipated expenses, changes in reserves, and adjustments made during the company&#8217;s closing and review/audit procedures;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z24662c5ade794cc9a8a6f7af00632993">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">adverse publicity related to the company&#8217;s business, products, industry or any legal actions or complaints by the company&#8217;s sales force or others;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z472ea76c6b474e9f9c680396a35e0a6b">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">risk that direct selling laws and regulations in any of our markets, including the United States and Mainland China, may be modified, interpreted or enforced in a manner that results in negative changes to
                  our business model or negatively impacts our revenue, sales force or business, including through the interruption of sales activities, loss of licenses, imposition of fines, or any other adverse actions or events;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze38fec444eaa441993978813d875f42b">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">any failure of current or planned initiatives or products to generate interest among the company&#8217;s sales force and customers and generate sponsoring and selling activities on a sustained basis;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z076323443f9246e1969eb0fee16a1f44">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">risk of foreign-currency fluctuations and the currency translation impact on the company&#8217;s business associated with these fluctuations;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z18b5e3b23369421b81a7fffa8b18728d">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">uncertainties regarding the future financial performance of the company&#8217;s recent acquisitions;</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageFooter"></div>
      <div style="page-break-after:always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5fea300e8d3041acbe17a27f589fa6ef">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, and increased risk of inventory write-offs if the
                  company over-forecasts demand for a product or changes its planned initiatives or launch strategies;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf6ae7af0700a41889c15bf7c99a4f473">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">regulatory risks associated with the company&#8217;s products, which could require the company to modify its claims or inhibit the company&#8217;s ability to import or continue selling a product in a market if it is
                  determined to be a medical device or if it is unable to register the product in a timely manner under applicable regulatory requirements;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd24ce7b226974609bfbc323e4843ac64">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">unpredictable economic conditions and events globally;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0adc4c350e9f4028a8e334cde18494f7">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">uncertainties related to interpretation of, and forthcoming regulations under, the recently enacted U.S. tax reform legislation; the company&#8217;s future tax-planning initiatives; any prospective or
                  retrospective increases in duties on the company&#8217;s products imported into the company&#8217;s markets outside of the United States; and any adverse results of tax audits or unfavorable changes to tax laws in the company&#8217;s various markets; and</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z00a8dd29b4a74a9aa02b8a3377d2589f">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div style="font-style: italic;">continued competitive pressures in the company&#8217;s markets.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div style="font-style: italic;">The company&#8217;s financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the
      Securities and Exchange Commission. The forward-looking statements set forth the company&#8217;s beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this
      release to reflect any change except as required by law.</div>
    <div><br>
    </div>
    <div style="text-align: center; color: #000000;"># # #</div>
    <div><br>
    </div>
    <div><font style="font-weight: bold; color: #363636;">CONTACTS:</font><br>
      <font style="color: #363636;">Media:&#160;</font><u>media@nuskin.com</u><font style="color: #363636;">, (801) 345-6397</font></div>
    <div><font style="color: #363636;">Investors:&#160;</font><u>investorrelations@nuskin.com</u><font style="color: #363636;">, (801) 345-3577<br>
      </font></div>
    <div><font style="color: #363636;"> <br>
      </font></div>
    <div><font style="color: #363636;"> <br>
      </font></div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  T *T# 2(  A$! Q$!_\0
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MU@6+?C.,[0,XR?SKQ+X$_#3POK?PF\/:CJ-K?/=SQ.TC1ZI=1*2)7'"I(%'
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G9/ACX6L8]&.N:@\^JZSK21SWEW?[9';"X5% 4*JKDX  ZT44 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
